Oncology: Genomics, Precision Medicine and Therapeutic Targets

This book describes translational cancer therapeutics and the way  forward from clinical and molecular diagnosis to treatment. In addition,  genomics alterations, microRNAs, and long non-coding RNAs translate  precision medicine for the individualistic therapy of cancer patients.  It describes the involvement of various pharmacogenetic factors in  pharmacodynamic/pharmacokinetic (PD/PK) modulations of medicines.  Indeed, the role of bioinformatics and biostatistics, considering the  extensive data analysis serving precision medicine approaches, has also  been entertained in the present book. Therefore, intended book  demonstrates the successful medical evidence for the use of precision  medicine in the treatment of cancer and its future clinical  perspectives. It fills the gaps in cancer biology and precision medicine  with its up-to-date content and well-designed chapters. It will serve  as a valuable resource for science, medical students, and  interdisciplinary researchers. It is a very welcome addition for the  scientific community, research centers, and university-industry research  collaborators to find out a complete capsular package about cancer drug  targets, precision, and personalized medicine (including an  introduction to cancer cell signaling, genomic alterations, miRNA  targeting, pharmacogenetics, biomarkers, and metabolomics in precision  medicine, etc.) at a single platform.